Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)H Fensterer, Thomas M. Gress, Hans‐Helge Müller et al.|Annals of Oncology|2013Cited by 31